课题基金 / 基金详情

The Role of Mucolipin 1 Block in Transition Metal Toxicity

The Role of Mucolipin 1 Block in Transition Metal Toxicity
Mucolipin 1 嵌段在过渡金属毒性中的作用
批准号:
7658637
负责人:
KIRILL KISELYOV
金额:
$22.11万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-01 至 2011-04-30

项目摘要

项目成果

KIRILL KISELYOV的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):过渡金属如Cu, Fe, Co具有众所周知的毒性作用。大部分过渡金属的摄取是通过溶酶体发生的,过量模型显示了过渡金属在溶酶体中的积累。过渡金属对溶酶体消化机制的影响尚未得到很好的证实。本项目获得的初步数据表明,过渡金属阻断离子通道粘脂蛋白1 (TRPML1)。TRPML1先前被确定为溶酶体离子通道突变,导致溶酶体储存病IV型粘脂质沉积症(MLIV)。与TRPML1下调在MLIV中的作用类似,TRPML1被过渡金属阻断与细胞质储存体的形成、线粒体断裂和线粒体Ca2+缓冲的丧失有关。通过类比溶酶体贮积性疾病中衰老和细胞死亡的溶酶体-线粒体轴模型,这些数据表明TRPML1被过渡金属阻断会影响溶酶体功能,从而影响自噬。抑制自噬导致功能失调线粒体的积累,这些线粒体不能吸收细胞质Ca2+并保护细胞免受Ca2+峰值的促凋亡作用。该建议的中心前提是:如果TRPML1阻断有助于过渡金属毒性,那么所有阻断TRPML1的过渡金属都应该诱导相同的mliv样表型。这种新模型的溶酶体贡献过渡金属毒性将使用几种方法进行测试。首先,将建立阻断TRPML1的过渡金属的范围,以便将金属阻断TRPML1与这种阻断诱导的溶酶体储存表型联系起来。是否所有阻断TRPML1的过渡金属都诱导自噬抑制和线粒体的积累,这些线粒体的Ca2+缓冲功能受损,将被确定。TRPML1被过渡金属阻断的结构决定因素将被建立,过渡金属抗性突变体将被创建。这些突变体将被用来取代天然的TRPML1,并确定TRPML1阻断对过渡金属溶酶体毒性的相对贡献。在这个项目中获得的结果有望确定过渡金属的溶酶体积累和细胞死亡之间的新联系,并可能为过渡金属毒性的新药理学方法提供理论基础。该项目的基本生物学意义包括更好地了解有毒金属的影响,离子通道的结构和功能以及溶酶体的清洁作用。
英文摘要
DESCRIPTION (provided by applicant): Transition metals such as Cu, Fe, Co have well known toxic effects. A large fraction of the transition metal uptake occurs through lysosomes and accumulation of transition metals in lysosomes was shown in the overload models. The effects of transition metals on lysosomal digestive machinery are not very well established. The preliminary data obtained for this project show that transition metals block ion channel mucolipin 1 (TRPML1). TRPML1 was previously identified as the lysosomal ion channel mutations in which cause lysosomal storage disease mucolipidosis type IV (MLIV). Similar to the effects of TRPML1 downregulation in MLIV, TRPML1 block by transition metals is associated with formation of cytoplasmic storage bodies, mitochondrial fragmentation and the loss of Ca2+ buffering by mitochondria. By analogy with the lysosome-mitochondria axis model of aging and cell death in lysosomal storage diseases, these data suggest that TRPML1 block by transition metals affects lysosomal function and, therefore autophagy. Suppressed autophagy results in accumulation of dysfunctional mitochondria that cannot take up cytoplasmic Ca2+ and guard cells against pro-apoptotic effects of Ca2+ spikes. The central premise of this proposal is: if TRPML1 block contributes to transition metals toxicity, then all transition metals that block TRPML1 should induce the same MLIV-like phenotype. This novel model of the lysosomal contribution to transition metal toxicity will be tested using several approaches. First, the range of transition metals that block TRPML1 will be established in order to correlate TRPML1 block by metals and lysosomal storage phenotype induced by such block. Whether or not all transition metals that block TRPML1 induce autophagy suppression and accumulation of mitochondria that are compromised in their Ca2+ buffering function will be established. Structural determinants of TRPML1 block by transition metals will be established and transition metal resistant mutants will be created. Such mutants will be used to replace native TRPML1 and establish the relative contribution of TRPML1 block into lysosomal toxicity of transition metals. The results obtained in the course of this project are expected to identify a novel link between lysosomal buildup of transition metals and cell death and may provide a rationale for novel pharmacological approaches to transition metals toxicity. The basic biological implications of this project include better understanding of the effect of toxic metals, structure and function of ion channels and housekeeping role of lysosomes. PUBLIC HEALTH RELEVANCE: The present project aims to answer whether the block of the lysosomal ion channel TRPML1 contributes to transition metal toxicity. Delineating the chain of events that connects lysosomal accumulation of transition metals to cell death will pave way for a detailed inquiry into lysosomal aspects of transition metal toxicity and may suggest novel pharmacological approaches to complement the existing treatments for metal toxicity. Since lysosomes are involved in the organism-level functions such as antigen processing, proving that transition metals affect lysosomal function may have even broader biological impact.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of mitochondrial GDAP1 in Alzheimer's disease
The TRPML1 Role in Lysosomes
The TRPML1 Role in Lysosomes
The TRPML1 Role in Lysosomes
海外基金